Testing a new artificial tear versus Optive in healthy adults
Part of Eyes & vision clinical trials.
This trial tests a new eye drop called PRO-240 versus Optive artificial tears in healthy adults. You will attend several visits over a few weeks and use the assigned drops as directed. The goal is to see if the new drop is as safe and comfortable as the standard one.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and in good general health.
- Your eyes are healthy — no glaucoma, recent eye surgery, or active infections.
- You have not taken any other eye drops or certain anti-inflammatory drugs in the last 30 days.
- If you wear contact lenses, you must stop wearing them 2 weeks before and during the study.
- Women who can become pregnant must use effective birth control (started at least 30 days before the study).
- You do not have any chronic conditions like diabetes, high blood pressure, or heart disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different dry-eye eye drops to see which works better and is safe. You may be able to join if you’ve had dry eye for at least 3 months and meet specific eye-test results.
This trial tests a medical device eye ointment called Vit-A-Vision for people with dry eye disease. It aims to see if the ointment can improve symptoms and tear film stability over about a month.
This trial studies whether BUFY01 eye drops work better than SVS20 for treating dry eye disease. You may be able to join if you have dry eye symptoms for at least 3 months and meet eye exam score and tear-test requirements.
This study tests a new eye drop (PRO-190) against a common artificial tear (Systane Ultra) to see how safe and comfortable it is. Healthy volunteers will use the drops and be monitored for any side effects or changes in their eyes.
This trial tests a new eye drop, Drop 0.4%, for people with dry eye. It includes both people who wear contact lenses and those who don’t, to see if the drop is safe and helps with symptoms.
This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.
Hear when a new Ocular Surface Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.